Conference Dates

June 12 – 17, 2022


Biopharmaceuticals are often intrinsically unstable and can rely on freeze-drying as a standard approach for stabilization. Although a standard, this process has long cycle times, is a batch drying process, and is incompatible with flexible manufacturing. There is need for advancing novel approaches that enable the vision for “a maximally efficient, agile, flexible, manufacturing sector that reliably produces high-quality drug products without extensive regulatory oversight;” (2004, FDA Pharmaceutical Quality for the 21st century).

Please click Download on the upper right corner to see the full abstract.